We are tracking the following list of medications (and groups of medications) to assess for COVID-related shortages:
| ATC | Description |
|---|---|
| C01CA | Adrenergics |
| H01BA | Vasopressin and analogues |
| M03AB01 | Succinylcholine (suxamethonium) |
| M03AC | Muscle relaxants (e.g. paralytics) |
| N01A | Anesthetics (includes opioid, ketamines) |
| N05CD | Benzodiazepines |
| N05CM18 | Dexmedetomidine |
| C01BD01 | Amiodarone |
| C03CA01 | Furosemide |
| J05AR10 | Kaletra (anti-viral) |
| N02BE01 | Acetaminophen (Paracetamol) |
| P01BA02 | Hydroxychloroquine |
| R01AA04 | Phenylephrine (nasal) |
| R03AC | Respiratory Beta Agonists |
The following charts shows the availability of COVID-19 indicator medications since November 2019. Only medications (by ATC code) that have had a shortages will be shown.